scholarly journals Gamma‐aminobutyric acid production by Lactobacillus brevis A3: Optimization of production, antioxidant potential, cell toxicity, and antimicrobial activity

2020 ◽  
Vol 8 (10) ◽  
pp. 5330-5339
Author(s):  
Behrooz Alizadeh Behbahani ◽  
Hossein Jooyandeh ◽  
Fereshteh Falah ◽  
Alireza Vasiee
Keyword(s):  
Antimicrobial Activity ◽  
Acid Production ◽  
Lactobacillus Brevis ◽  
Antioxidant Potential ◽  
Aminobutyric Acid ◽  
Gamma Aminobutyric Acid ◽  
Cell Toxicity

scholarly journals Optimization of Gamma Aminobutyric Acid Production Using High Pressure Processing (HPP) by Lactobacillus brevis PML1

2022 ◽  
Vol 2022 ◽  
pp. 1-9
Author(s):  
Atefe Ghafurian Nasab ◽  
Sayed Ali Mortazavi ◽  
Farideh Tabatabaei Yazdi ◽  
Mahboobe Sarabi Jamab
Keyword(s):  
High Performance ◽  
Morphological Changes ◽  
Control Sample ◽  
Bioactive Compound ◽  
Lactobacillus Brevis ◽  
High Pressure Processing ◽  
Aminobutyric Acid ◽  
Gamma Aminobutyric Acid ◽  
Viability Analysis ◽  
Layer Chromatography

In the present research, the production potential of gamma aminobutyric acid (GABA) using Lactobacillus brevis PML1 was investigated. In addition, the microorganism viability was examined in MAN, ROGOSA, and SHARPE (MRS) after undergoing high hydrostatic pressure at 100, 200, and 300 MPa for 5, 10, and 15 min. Response surface methodology (RSM) was applied to optimize the production conditions of GABA as well as the bacteria viability. Analysis of variance (ANOVA) indicated that both the independent variables (pressure and time) significantly influenced the dependent ones (GABA and bacteria viability) ( P < 0.05 ). The optimum extraction conditions to maximize the production of GABA included the pressure of 300 MPa and the time of 15 min. The amount of the compound was quantified using thin-layer chromatography (TLC) and spectrophotometry. For the process optimization, a central composite design (CCD) was created using Design Expert with 5 replications at the center point, whereby the highest content of GABA was obtained to be 397.73 ppm which was confirmed by high performance liquid chromatography (HPLC). Moreover, scanning electron microscopy (SEM) was utilized to observe the morphological changes in the microorganism. The results revealed that not only did have Lactobacillus brevis PML1 the potential for the production of GABA under conventional conditions (control sample) but also the content of this bioactive compound could be elevated by optimizing the production parameters.

Sign in / Sign up

Export Citation Format

Share Document